Ontology highlight
ABSTRACT:
SUBMITTER: Favaretto C
PROVIDER: S-EPMC10853284 | biostudies-literature | 2024 Feb
REPOSITORIES: biostudies-literature
Favaretto C C Grundler P V PV Talip Z Z Köster U U Johnston K K Busslinger S D SD Sprung P P Hillhouse C C CC Eichler R R Schibli R R Müller C C van der Meulen N P NP
Scientific reports 20240208 1
Terbium-149 (T<sub>1/2</sub> = 4.1 h, E<sub>α</sub> = 3.98 MeV (16.7%), 28 µm range in tissue) is a radionuclide with potential for targeted alpha therapy. Due to the negligible emission of α-emitting daughter nuclides, toxicity to healthy tissue may be reduced in comparison with other α-particle emitters. In this study, terbium-149 was produced via 1.4 GeV proton irradiation of a tantalum target at the CERN-ISOLDE facility. The spallation products were mass separated and implanted on zinc-coate ...[more]